Sleep deprivation is associated with risk of atherosclerosis in adults: JAHA

Published Date: 17 Feb 2023

United States: Infrequent sleep, particularly chronic sleep, in adults aged 45 and older is associated with numerous measures of...

Read Full News

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Expert Consensus on Knowledge Gaps in Dermatology for Skin of Color, With Henry Lim, MD Henry Lim, MD

This interview with Lim highlights knowledge gaps examined by an international expert panel reviewing existing literature on dermatologic disease in skin of color.

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

A phase 3b study presented at ACTRIMS 2026 is evaluating whether switching to remibrutinib offers efficacy and safety comparable to continued ocrelizumab treatment in relapsing multiple sclerosis.

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

A phase 3b study presented at ACTRIMS 2026 is evaluating whether switching to remibrutinib offers efficacy and safety comparable to continued ocrelizumab treatment in relapsing multiple sclerosis.

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

This interview with Lim highlights knowledge gaps examined by an international expert panel reviewing existing literature on dermatologic disease in skin of color.

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

News All Time

Practical Approaches to Hyperpigmentation and Hypopigmentation, With Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

This segment of the latest Skin of Color Savvy episode highlights a conversation between Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS.

Skin of Color Savvy: Highlights from 2025 Tim Smith

In this end-of-year reel, HCPLive has showcased several key highlights from the Skin of Color Savvy podcast in 2025.

Skin of Color Savvy: On-Site Interviews at the Meeting the Challenge Summit Angel S. Byrd, MD, PhD, Valerie D. Callender, MD, Valerie Harvey, MD, MPH, Stafford Brown, MD, MBA

This episode of Skin of Color Savvy was filmed on-site at the Skin of Color Society's 'Meeting the Challenge Summit' in Washington, DC.

Skin of Color Savvy: Highlights From the Most-Watched Episodes of 2025 Andrew F Alexis, MD, MPH, Shawn Kwatra, MD, Crystal Aguh, MD, FAAD, John E. Harris, MD, PhD, Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

This new episode from January 2026 features a compilation of 3 clips from the most viewed episodes of 2025.

Maui Derm 2026 Presentation Highlights Icotrokinra, Other New Dermatology Drugs

The HCPFive: Top News for Healthcare Providers from the Week of 01/18

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

LEVEL UP: New Data on Switching from Dupilumab to Upadacitinib in Atopic Dermatitis

Personalized Care Improvements Identified for Older Patients with Skin Cancer

What to Expect at the 2026 Maui Derm Conference

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups

ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis

Unmet Needs Highlighted Regarding CSU Treatment Escalation

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

For treatment, the majority of cancer patients choose complementary therapies.

3.

Food insecurity linked to tumor growth in pediatric neuroblastoma

4.

Getting ahead of head and neck cancer

5.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

1.

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies

2.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

3.

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients

4.

Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology

5.

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

2.

Current Scenario of Cancer- Q&A Session to Close the Gap

3.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

4.

Should We Use DARA Up Front As First-Line Therapy in MM?

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Sleep deprivation is associated with risk of atherosclerosis in adults: JAHA

Latest News

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Updated Urticaria Guidelines Clarify Diagnosis, Biomarkers, Treatment Pathways

6 Dermatology Headlines You Missed in January 2026

Bimekizumab Demonstrates Long Term Efficacy in Hidradenitis Suppurativa

Expert Consensus on Knowledge Gaps in Dermatology for Skin of Color, With Henry Lim, MD Henry Lim, MD

Upadacitinib Regulatory Applications Submitted for Adults, Adolescents with Vitiligo

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

Todays Updates

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib Isabella Ciccone, MPH

Latest News

News All Time

Practical Approaches to Hyperpigmentation and Hypopigmentation, With Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

Skin of Color Savvy: Highlights from 2025 Tim Smith

Skin of Color Savvy: On-Site Interviews at the Meeting the Challenge Summit Angel S. Byrd, MD, PhD, Valerie D. Callender, MD, Valerie Harvey, MD, MPH, Stafford Brown, MD, MBA

Skin of Color Savvy: Highlights From the Most-Watched Episodes of 2025 Andrew F Alexis, MD, MPH, Shawn Kwatra, MD, Crystal Aguh, MD, FAAD, John E. Harris, MD, PhD, Nada Elbuluk, MD, MSc, Michelle Rodrigues, MBBS

Maui Derm 2026 Presentation Highlights Icotrokinra, Other New Dermatology Drugs

The HCPFive: Top News for Healthcare Providers from the Week of 01/18

Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and Older

LEVEL UP: New Data on Switching from Dupilumab to Upadacitinib in Atopic Dermatitis

Personalized Care Improvements Identified for Older Patients with Skin Cancer

What to Expect at the 2026 Maui Derm Conference

New Findings on Acne Incidence in Transgender Individuals, With Howa Yeung, MD, MSc

Topical Antioxidant Serum May Be Effective in Treating Atrophic Acne Scars

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Ritlecitinib Efficacious for Non-Segmental Vitiligo Across Various Subgroups

ICP-332 Effective, Safe for Treating Moderate to Severe Atopic Dermatitis

Unmet Needs Highlighted Regarding CSU Treatment Escalation

Recommended News For You

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

AI-based breast cancer risk technology receives FDA breakthrough device designation

O. A. J. Simpson passes away from cancer.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

Prostate cancer early detection system eliminates need for biopsy.

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Recommended Articles For You

Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.